Objectives: This study aims to investigate the possible relationship between smoking and otorhinolaryngological symptoms in smokers, nonsmokers and ex-smokers.
Smoking is known to have harmful effects on health [1] and cigarette smoking and passive smoking are widespread in the world. However, associated diseases are not considered important enough as consequences arise indirectly and after a long period of time. Inhalation of tobacco smoke causes chronic irritation in the nose and oropharynx of both active and passive smokers. Four thousand harmful components such as acrolein, formaldehyde, carbon monoxide, nicotine, acetaldehyde, phenol, potassium cyanide that are present in cigarette smoke, are toxic to respiratory epithelium. [2] This study aimed to demonstrate whether there is a statistically significant difference between smokers, ex-smokers and controls regarding symptoms of ENT diseases. We applied a questionnaire including symptoms of ENT disorders on randomly selected patients.
PATIENTS AND METHODS
This is a randomized-controlled prevalence and incidence study which included 1,840 randomly selected patients (823 males, 1,017 females) over 25 years of age who were admitted to the ear, nose, and throat (ENT) outpatient clinic between March 01 st , 2014 and March 31 st , 2014. The study protocol was approved by the Dr. Lütfi Kırdar Kartal Training and Research Hospital Ethics Committee. Written informed consent was obtained from each patient, and the study was conducted in accordance with the principles of the Declaration of Helsinki. The same doctors filled forms containing the symptoms of ENT diseases. Patients who had been smoking at least 10 cigarettes daily for at least five years were included in the smokers group (n=514). Patients who did not smoke for at least one year after at least five years of smoking were included in the ex-smokers group (n=268). Patients who never smoked were included in the non-smokers control group (n=1,058). Patients with obvious pathology that explained the symptoms or with acute infection were excluded from the study. Passive smokers were excluded from the study. Statistical evaluation of the data analysis was performed with Fischer's chi-square test (p<0.05).
RESULTS
Patient demographics are shown in Table 1 . Laryngopharyngeal symptoms are summarized in Table 2 : cough, shortness of breath, and reflux were found to be significantly increased in smokers compared to the control group, and cough, sputum, hoarseness, dysphagia, and reflux were significantly lower among ex-smokers.
Oral cavity symptoms are summarized in Table 3 : dryness of throat, irritation, taste disorder, bad breath and toothache were significantly increased in smokers compared to the control group but mouth sores were found to be lower. There were no significant differences among other symptoms. Sore throat, dryness of throat, irritation, sore throat, stinging, mouth sores (oral aphthae), taste disorders, toothache and bleeding gums and bad breath were found to be significantly lower among ex-smokers.
Sinonasal symptoms are listed in Table 4 : nasal congestion, smell disorders and snoring were significantly higher among smokers compared to the control group, while nasal congestion, runny nose, nosebleeds, sneezing, nasal discharge, smell disorders, headache, and facial fullness were statistically significantly lower in ex-smokers.
Ear symptoms are listed in Table 5 : discharge was higher among smokers compared to the control group, whereas ear pain was significantly lower. There were no significant differences among other symptoms. Ear discharge, hearing loss, pain, fullness, dizziness and tinnitus were significantly lower among ex-smokers.
DISCUSSION
Laryngopharyngeal reflux may be related to smoking. In a study on effects of acute and chronic smoking on upper esophageal contractile reflex and pharyngeal swallowing, smoking was recorded to have reverse effects on this reflex and to cause reflux. [3] We also found a significantly higher rate of reflux in smokers. Although difficulty in swallowing was higher in smokers, there was no statistical difference compared to the control group. Cigarette smoke causes reflex changes in the upper airways during breathing. [4] Chronic smoking causes metaplasia in respiratory mucosa, increase of goblet cells and increase in upper respiratory tract secretions. [2, 5] In our study, sputum symptoms were found in 29.4% of non-smokers and in 51% of smokers (p>0.19; not significant). Sputum complaints were significantly lower in ex-smokers (20.5%).
Smoking has been shown to be associated with structural changes besides functional changes in the respiratory epithelium. Different studies have showed that cigarette smoke decreases the vital functions of the cells, induces apoptosis in the respiratory epithelium, [6] reduces mitogenic effect and that proapoptotic activity is found to be dependent on cigarette smoke concentration or cause significant decreases in the regeneration of damaged epithelium. [7] In a study conducted on dogs, cigarette smoke has been shown to cause bradypnea and that the respiratory reflex is carried by afferent sensory pathways. [8] These studies illustrate the shortness of breath due to smoking. In our study, shortness of breath was significantly higher in smokers. In one study, lung functions were significantly improved and cough had been shown to decrease after implementation of a 12-month ban among chronic cigarette smokers. [9] Alcohol use together with smoking increases laryngeal disease risk even more in future years. [10] Although smoking and alcohol use did not independently increase the likelihood of chronic voice disorders in a large incidence [11] Cigarette smoking can cause oral fibrosis. Nicotine can directly increase the production of collagen in gingival fibroblasts and develop periodontal fibrosis. [12] We also found higher dryness of throat due to oral fibrosis, irritability, toothache and bad breath due to gingivitis among smokers in our study. In another survey, current or past smoking has been identified as an important factor in bad breath as well as poor oral hygiene. [13] Cigarette smoking is a leading cause of oral malodor. [14] Oral and nasopharyngeal flora of smokers contain fewer aerobic and anaerobic microorganisms and contain more potential pathogens. This would explain the pharyngitis symptoms in smokers (burning in the throat, dryness, irritation, pain, etc.). The flora returns to normal when smoking is ceased. [15] Likewise subgingival flora changes highly. [16] Interestingly, we found significantly lower oral cavity symptoms in ex-smokers compared to the control group. We think that this situation is due to patients better realizing improvement of their symptoms as they feel their symptoms more during smoking.
Smokers and non-smokers with chronic tonsillitis were compared and a longer history of recurrent tonsillitis and marked morphological changes were identified in smokers. [17] In our study, sore throat due to tonsillitis and pharyngitis was found to be lower in ex-smokers, whereas there was no difference in smokers.
Smoking is a risk factor for infectious diseases affecting the respiratory tract. [18] Bacteria obtained from patients with cigarette smoke exposure return to the bacteria phenotype that does not form biofilm when smoke is interrupted. These observations support the hypothesis of sinonasal biofilm formation, and thus persistent infections are observed although these infections can be treated medically. [19] Headache, runny nose, dysphagia, odynophagia, pharyngeal irritation, dryness of the throat and chronic pharyngitis symptoms occur more frequently in these patients. In our study, while nasal congestion, smell disorders and snoring were significantly higher in smokers; symptoms such as runny nose, sneezing, nasal discharge and headache were close to the control group. All symptoms were found to be significantly lower in ex-smokers. In a study, application of tobacco smoke for 30 minutes to healthy non-smokers was observed to increase nasal congestion, and rhinitis symptoms and nasal congestion were found in the results of the survey. [20] Sinusitis patients and patients smoking more than one pack of cigarettes a day for more than five years were shown to have a prolonged mucociliary transit time compared to the normal control group. [21] A study in North America showed a significant increase in the incidence of chronic and recurrent rhinosinusitis in patients who smoke at least 10 cigarettes a day compared to non-smokers and ex-smokers. [2] We also considered smoking addiction as smoking at least 10 cigarettes a day for at least five years. Regarding the literature, nasal polyp in smokers did not differ significantly compared to the control group. [22] In a prevalence study in Korea, smoking was reported to have very little effect on the prevalence of allergic rhinitis. [23] In our study, allergic rhinitis symptoms were also not statistically significantly different compared to the control group and was lower in ex-smokers.
A survey showed that body aches such as fibromyalgia, neck pain, and headache appeared to be higher in female smokers. [24] A study in which 204 articles were scanned revealed definite evidences that active smoking or passive exposure contributes to the formation of chronic rhinosinusitis. [25] Although cochlear dysfunction and tinnitus are seen more often in smokers, the relationship between smoking and ear pathology is not certain. [26] Smoking is not associated with a significant increase in the risk of hearing loss. [27] In a study conducted on 13,308 male patients, hearing loss incidence was significantly higher in smokers compared to nonsmokers and this effect was more prominent in youth. [28] In our study, the incidence of hearing loss was not significant in smokers. It was significantly lower in ex-smokers. In an incidence study similar to our study; although ear discharge, ear pain, hearing loss, dizziness and tinnitus were more common in smokers, there was no statistical significance except for dizziness and tinnitus. [29] In a study of factors affecting tinnitus prevalence, smoking has been shown not to have an important role among other factors. [30] In conclusion, our study showed that although the majority of laryngopharyngeal and oral cavity symptoms were significantly higher in smokers compared to nonsmokers, sinonasal and ear symptoms were generally not significantly higher in smokers. The majority of symptoms of ENT diseases were significantly lower in ex-smokers compared to the control group. We believe that some discordance with the literature is due to low socioeconomic status of our patient population, ignorance of present symptoms by smokers, and ex-smokers being more aware of post-smoking symptom changes.
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